Current and potential future drug therapies for tension-type headache

Current Pain and Headache Reports

Volumn 7, Issue 6, 2003, Pages 466-474

  Ashina, Sait ^a   Ashina, Messoud ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMITRIPTYLINE; AMITRIPTYLINOXIDE; ANALGESIC AGENT; ANTIPYRETIC AGENT; BOTULINUM TOXIN; CAFFEINE; CITALOPRAM; CODEINE; DICLOFENAC POTASSIUM; DIPYRONE; IBUPROFEN; KETOPROFEN; KETOROLAC; MUSCLE RELAXANT AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NAPROXEN; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIATE; PARACETAMOL; PLACEBO; RECEPTOR BLOCKING AGENT; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

CHRONIC PAIN; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DOSE RESPONSE; DRUG CHOICE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG SPECIFICITY; GASTROINTESTINAL SYMPTOM; HUMAN; NEUROSCIENCE; RECEPTOR BLOCKING; REVIEW; SOCIOECONOMICS; TENSION HEADACHE; DRUG COMBINATION; FORECASTING;

ANALGESICS; DRUG THERAPY, COMBINATION; FORECASTING; HUMANS; TENSION-TYPE HEADACHE;

EID: 1542501097     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-003-0063-8     Document Type: Review

References (84)

1. Schwartz BS, Stewart WF, Simon D, Lipton RB: Epidemiology of tension-type headache. JAMA 1998, 279:381-383.
2. Rasmussen BK, Jensen R, Schroll M, Olesen J: Epidemiology of headache in a general population: a prevalence study. J Clin Epidemiol 1991, 44:1147-1157.
3. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 1988, 8(suppl 7):1-96.
4. von Graffenried B, Nuesch E: Non-migrainous headache for the evaluation of oral analgesics. Br J Clin Pharmacol 1980, 10(suppl 2):225S-231S.
5. Diamond S: Ibuprofen versus aspirin and placebo in the treatment of muscle contraction headache. Headache 1983, 23:206z-210z.
6. Langemark M, Olesen J: Effervescent ASA versus solid ASA in the treatment of tension headache: a double-blind, placebo-controlled study. Headache 1987, 27:90-95.
7. Martinez-Martin P, Raffaelli E Jr, Titus F, et al.: Efficacy and safety of metamizol vs acetylsalicylic acid in patients with moderate episodic tension-type headache: a randomized, double-blind, placebo- and active-controlled, multicentre study. Cephalalgia 2001, 21:604-610.
8. Nebe J, Heier M, Diener HC: Low-dose ibuprofen in self-medication of mild to moderate headache: a comparison with acetylsalicylic acid and placebo. Cephalalgia 1995, 15:531-535.
9. Peters BH, Fraim CJ, Masel BE: Comparison of 650 mg aspirin and 1000 mg acetaminophen with each other, and with placebo in moderately severe headache. Am J Med 1983, 74:36-42.
10. Ryan RE: Motrin: a new agent for the symptomatic treatment of muscle contraction headache. Headache 1977, 16:280-283.
11. Steiner TJ, Lange R, Voelker M: Aspirin in episodic tension-type headache: placebo-controlled dose-ranging comparison with paracetamol. Cephalalgia 2003, 23:59-66.
12. Dahlof CG, Jacobs LD: Ketoprofen, paracetamol, and placebo in the treatment of episodic tension-type headache. Cephalalgia 1996, 16:117-123.
13. Mehlisch DR, Weaver M, Fladung B: Ketoprofen, acetaminophen, and placebo in the treatment of tension headache. Headache 1998, 38:579-589.
14. Migliardi JR, Armellino JJ, Friedman M, et al.: Caffeine as an analgesic adjuvant in tension headache. Clin Pharmacol Ther 1994, 56:576-586.
15. Packman B, Packman E, Doyle G, et al.: Solubilized ibuprofen: evaluation of onset, relief, and safety of a novel formulation in the treatment of episodic tension-type headache. Headache 2000, 40:561-567.
16. Prior MJ, Cooper KM, May LG, Bowen DL: Efficacy and safety of acetaminophen and naproxen in the treatment of tension-type headache: a randomized, double-blind, placebo-controlled trial. Cephalalgia 2002, 22:740-748.
17. Schachtel BP, Thoden WR, Konerman JP, et al.: Headache pain model for assessing and comparing the efficacy of over-the-counter analgesic agents. Clin Pharmacol Ther 1991, 50:322-329.
18. Schachtel BP, Furey SA, Thoden WR: Nonprescription ibuprofen and acetaminophen in the treatment of tension-type headache. J Clin Pharmacol 1996, 36:1120-1125.
19. Steiner TJ, Lange R: Ketoprofen (25 mg) in the symptomatic treatment of episodic tension-type headache: double-blind placebo-controlled comparison with acetaminophen (1000 mg). Cephalalgia 1998, 18:38-43.
20. Miller DS, Talbot CA, Simpson W, Korey A: A comparison of naproxen sodium, acetaminophen and placebo in the treatment of muscle contraction headache. Headache 1987, 27:392-396.
21. Schachtel BP, Furey SA, Thoden WR: Nonprescription ibuprofen and acetaminophen in the treatment of tension-type headache. J Clin Pharmacol 1996, 36:1120-1125.
22. Bigal ME, Bordini CA, Speciali JG: Intravenous metamizol (Dipyrone) in acute migraine treatment and in episodic tension-type headache: a placebo-controlled study. Cephalalgia 2001, 21:90-95.
23. Schachtel BP, Thoden WR: Onset of action of ibuprofen in the treatment of muscle-contraction headache. Headache 1988, 28:471-474.
24. Diamond S, Balm TK, Freitag FG: Ibuprofen plus caffeine in the treatment of tension-type headache. Clin Pharmacol Ther 2000, 68:312-319.
25. Harden RN, Rogers D, Fink K, Gracely RH: Controlled trial of ketorolac in tension-type headache. Neurology 1998, 50:507-509.
26. Kubitzek F, Ziegler G, Gold MS, et al.: Low-dose diclofenac potassium in the treatment of episodic tension-type headache. Eur J Pain 2003, 7:155-162.
27. Van Gerven JMA, Schoemaker RC, Jacobs LD, et al.: Self-medication of single headache episode with ketoprofen, ibuprofen, or placebo, home-monitored with an electronic patient diary. Br J Clin Pharmacol 1996, 475-481.
28. McNeely W, Goa KL: Diclofenac-potassium in migraine: a review. Drugs 1999, 57:991-1003.
29. Friedman AP, DiSerio FJ: Symptomatic treatment of chronically recurring tension headache: a placebo-controlled, multicenter investigation of Fioricet and acetaminophen with codeine. Clin Ther 1987, 10:69-81.
30. Jensen R: Tension-type headache. Curr Treat Options Neurol 2001, 3:169-180.
31. Mathew NT, Schoenen J: Acute pharmacotherapy of tension-type headache. In The Headaches. Edited by Olesen J, Tfelt-Hansen P, Welch KM. Philadelphia: Lippincott-Raven; 2000:661-666.
32. Brennum J, Kjeldsen M, Olesen J: The 5-HT1-like agonist sumatriptan has a significant effect in chronic tension-type headache. Cephalalgia 1992, 12:375-379.
33. Cady RK, Gutterman D, Saiers JA, Beach ME: Responsiveness of non-IHS migraine and tension-type headache to sumatriptan. Cephalalgia 1997, 17:588-590.
34. Brennum J, Brinck T, Schriver L, et al.: Sumatriptan has no clinically relevant effect in the treatment of episodic tension-type headache. Eur J Neurol 1996, 3:23-28.
35. Goadsby PJ, Lipton RB, Ferrari MD: Migraine: current understanding and treatment. N Engl J Med 2002, 346:257-270.
36. Bendtsen L: Central sensitization in tension-type headache: possible pathophysioiogical mechanisms. Cephalalgia 2000, 20:486-508.
37. Mathew NT, Bendtsen L: Prophylactic pharmacotherapy of tension-type headache. In The Headaches. Edited by Olesen J, Tfelt-Hansen P, Welch KM. Philadelphia: Lippincott-Raven; 2000:667-673.
38. Lance JW, Curran DA: Treatment of chronic tension headache. Lancet 1964, 1:1236-1239.
39. Diamond S, Baltes BJ: Chronic tension headache treated with amitriptyline: a double-blind study. Headache 1971, 11:110-116.
40. Gobel H, Hamouz V, Hansen C, et al.: Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity, but does not alter pericranial muscle activity readings. Pain 1994, 59:241-249.
41. Pfaffenrath V, Diener HC, Isler H, et al.: Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multicentre controlled study. Cephalalgia 1994, 14:149-155.
42. Bendtsen L, Jensen R, Olesen J: A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry 1996, 61:285-290.
43. Bendtsen L, Jensen R: Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Cephalalgia 2000, 20:603-610.
44. Holroyd KA, O'Donnell FJ, Stensland M, et al.: Management of chronic tension-type headache with tricylic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA 2001, 285:2208-2215.
45. Sawynok J, Esser MJ, Reid AR: Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry/Neurosci 2001, 26:21-29.
46. Watanabe Y, Saito H, Abe K: Tricyclic antidepressants block NMDA receptor-mediated synaptic responses and induction of long-term potentiation in rat hippocampal slices. Neuropharmacology 1993, 32:479-486.
47. Eschalier A, Ardid D, Dubray C: Tricyclic and other antidepressants as analgesics. In Novel Aspects of Pain Management Opioids and Beyond. Edited by Sawynok JC, Cowan A. Hoboken, NJ: Wiley; 1997:301-319.
48. Singh NN, Misra S: Sertraline in chronic tension-type headache. J Assoc Physicians India 2002, 50:873-878.
49. Manna V, Bolino F, Di Cicco L: Chronic tension-type headache, mood depression, and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache 1994, 34:44-49.
50. Langemark M, Olesen J: Sulpiride and paroxetine in the treatment of chronic tension-type headache: an explanatory double-blind trial. Headache 1994, 34:20-24.
51. Fogelholm R, Murros K: Tizanidine in chronic tension-type headache: a placebo-controlled, double-blind, cross-over study. Headache 1992, 32:509-513.
52. Murros K, Kataja M, Hedman C, et al.: Modified-release formulation of tizanidine in chronic tension-type headache. Headache 2000, 40:633-637.
53. Guyer BM: Mechanism of botulinum toxin in the relief of chronic pain. Curr Rev Pain 1999, 3:427-431.
54. Smuts J, Baker MK, Smuts HM: Prophylactic treatment of chronic tension-type headache using botulinum toxin type A. Eur J Neurol 1999, 6(suppl 4):899-S102.
55. Göbel H, Lindner V, Krack PK, et al.: Treatment of chronic tension-type headache with botulinum toxin [Abstract]. Cephalalgia 1999, 19:455.
56. Rollnik JD, Tanneberger O, Schubert M, et al.: Treatment of tension-type headache with botulinum toxin type A: a double-blind, placebo-controlled study. Headache 2000, 40:300-305.
57. Schmitt WJ, Slowey E, Fravi N, et al.: Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache 2001, 41:658-664.
58. Bombardier C: An evidence-based evaluation of the gastrointestinal safety of coxibs. Am J Cardiol 2002, 89:3D-9D.
59. Gajraj NM: Cyclooxygenase-2 inhibitors. Anesth Analg 2003, 96:1720-1738.
60. Yaksh TL, Dirig DM, Conway CM, et al.: The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci 2001, 21:5847-5853.
61. Fogelholm R, Murros K: Maprotiline in chronic tension headache: a double-blind cross-over study. Headache 1985, 25:273-275.
62. Langemark M, Loldrup D, Bech P, Olesen J: Clomipramine and mianserin in the treatment of chronic tension headache: a double-blind, controlled study. Headache 1990, 30:118-121.
63. Horst WD, Preskorn SH: Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. J Affect Disord 1998, 51:237-254.
64. Morton WA, Sonne SC, Verga MA: Venlafaxine: a structurally unique and novel antidepressant. Ann Pharmacother 1995, 29:387-395.
65. Adelman LC, Adelman JU, Von Seggern R, Mannix LK: Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinical setting. Headache 2000, 40:572-580.
66. Kulaksizoglu IB, Cakir S, Erras M: Treatment of tension-type headache with mirtazapine [Abstract]. Proceedings of the 12th International Headache Research Seminar. Copenhagen: Match 7-9, 2003.
67. Mitsikostas DD, Gatzonis S, Thomas A, Ilias A: Buspirone vs amitriptyline in the treatment of chronic tension-type headache. Acta Neurol Scand 1997, 96:247-251.
68. Tremont-Lukats IW, Megeff C, Backonja MM: Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs 2000, 60:1029-1052.
69. Czuczwar SJ, Patsalos PN: The new generation of GABA enhancers: potential in the treatment of epilepsy. CNS Drugs 2001, 15:339-350.
70. Di Trapani G, Mel D, Marra C, et al.: Gabapentin in the prophylaxis of migraine: a double-blind, randomized, placebo-controlled study. Clin Ther 2000, 151:145-148.
71. Storey JR, Calder CS, Hart DE, Potter DL: Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache 2001, 41:968-975.
72. Lenaerts M, Bastings E, Sianard J, Schoenen J: Sodium valproate in severe migraine and tension-type headache: an open study of long-term efficacy and correlation with blood levels. Acta Neurol Belg 1996, 96:126-129.
73. Woolf CJ, Salter MW: Neuronal plasticity: increasing the gain in pain. Science 2000, 288:1765-1769.
74. Ashina M: Neurobiology of chronic tension-type headache. Cephalalgia, in press.
75. Willis WD: Role of neurotransmitters in sensitization of pain responses. Ann N Y Acad Sci 2001, 933:142-156.
76. Woolf CJ, Thompson SW: The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states. Pain 1991, 44:293-299.
77. Gu JG, Albuquerque C, Lee CJ, MacDermott AB: Synaptic strengthening through activation of Ca2+-permeable AMPA receptors. Nature 1996, 381:793-796.
78. Malinow R, Malenka RC: AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 2002, 25:103-126.
79. Wu J, Lin Q, McAdoo DJ, Willis WD: Nitric oxide contributes to central sensitization following intradermal injection of capsaicin. Neuroreport 1998, 9:589-592.
80. Mao J, Price DD, Zhu J, et al.: The inhibition of nitric oxide-activated poly (ADP-ribose) synthetase attenuates transsynaptic alteration of spinal cord dorsal horn neurons and neuropathic pain in the rat. Pain 1997, 72:355-366.
81. Hao JX, Xu XJ: Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered nitric oxide synthase inhibitors. Pain 1996, 66:313-319.
82. Haley JE, Dickenson AH, Schachter M: Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology 1992, 31:251-258.
83. Ramadan NM, Sang C, Chappell A, et al.: IV LY293558, an AMPA/KA receptor antagonist, is effective in migraine [Abstract]. Cephalalgia 2001, 21:267-268.
84. Ashina M, Lassen LH, Bendtsen L, et al.: Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet 1999, 353:287-289.